Pear Therapeutics

PEAR Therapeutics Completes $50 Million Series B

Temasek Joins Current Investors to Advance Prescription Digital Therapeutics Platform PEAR Therapeutics, the leader in prescription digital therapeutics, today announced that it has successfully closed a $50 million Series B financing led by Temasek. With…

BaseHealth CEO Jason Pyle

BaseHealth Raises $8.5 Million in Series C Funding

Company uses predictive analytics to uncover rising risk patients within a population BaseHealth, the creator of the first predictive, evidence-based, and data-driven population health management solution, today announced that it has received an overall investment…